2020
DOI: 10.1080/07391102.2020.1757511
|View full text |Cite
|
Sign up to set email alerts
|

Computational analysis of nuclear factor-κB and resveratrol in colorectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 38 publications
0
5
0
Order By: Relevance
“… 29 , 40 Hydrophobic interactions can occur between nonpolar or hydrophobic regions of molecules, with such interactions possibly contributing to stabilizing protein-ligand complexes. 41 Resveratrol, being a polyphenolic compound with a hydrophobic core, 42 is likely to engage in hydrophobic interactions with hydrophobic patches on NQO1 or other nearby residues. These interactions can facilitate the binding of resveratrol to NQO1 and influence its biological effects.…”
Section: Discussionmentioning
confidence: 99%
“… 29 , 40 Hydrophobic interactions can occur between nonpolar or hydrophobic regions of molecules, with such interactions possibly contributing to stabilizing protein-ligand complexes. 41 Resveratrol, being a polyphenolic compound with a hydrophobic core, 42 is likely to engage in hydrophobic interactions with hydrophobic patches on NQO1 or other nearby residues. These interactions can facilitate the binding of resveratrol to NQO1 and influence its biological effects.…”
Section: Discussionmentioning
confidence: 99%
“…Much evidence suggests that resveratrol is a multi-factorial bioactive phytochemical with numerous beneficial preventive effects on subcellular biological pathways, especially anti-inflammatory effects by inhibiting pro-inflammatory cytokines (IL-1β, TNF-α, and TNF-β), the pro-inflammatory transcription factor NF-κB and thus NF-κB-promoted end-proteins. A recent molecular docking study documented that resveratrol could be effective against CRC by targeting NF-κB signaling [ 206 ], and in this regard, our group described resveratrol’s NF-κB suppression by resveratrol associated with an anti-inflammatory mode of action in CRC [ 207 ]. Furthermore, a seven-day treatment with resveratrol (10mg/kg body weight) suppressed the dextran sulfate sodium-induced inflammatory colon injury via down-regulation of NF-κB, STAT3, ERK, and iNOS expressions in IRC mice [ 208 ].…”
Section: Resveratrol’s Versatile Anti-carcinogenic Effectsmentioning
confidence: 99%
“…In C33A, HeLa, CaLo, and CaSki cell cultures, the antiproliferative and proapoptotic activities of resveratrol were accompanied by a significant decrease in NF-κB p65 expression [ 263 ]. In human colon cancer cell cultures, resveratrol prevented nuclear translocation of NF-κB, presumably by binding to its monomer, and thus preventing its dimerization [ 264 ]. This phenolic compound was also able to suppress proliferation of human MV3 and A375 melanoma cells, both in culture and in a mouse xenograft model, by downregulating the expression of NF-κB and NF-κB-regulated miR-221, thus leading to the enhancement of the expression of TFG tumor suppressors, the mRNA of which is targeted by miR-221 [ 265 ].…”
Section: Tumor-promoting Inflammationmentioning
confidence: 99%